ArticlePharmaceutics2019

Development of a UV-Stabilized Topical Formulation of Nifedipine for the Treatment of Raynaud Phenomenon and Chilblains.

Ellen K Wasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.